Sphera Funds Management Ltd. Global Blood Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $1.21 Million - $2.03 Million	-24,752 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $2.3 Million - $4.82 Million	-55,248 Reduced 69.06%	24,752 $1.27 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $2.68 Million - $3.58 Million	-67,000 Reduced 45.58%	80,000 $4.23 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $4.64 Million - $6.86 Million	147,000 New	147,000 $6.03 Million
Q1 2018 May 10, 2018	SELL	$39.6 - $65.9 $3.96 Million - $6.59 Million	-100,000 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$29.7 - $45.7 $801,900 - $1.23 Million	-27,000 Reduced 21.26%	100,000 $3.94 Million
Q3 2017 Nov 09, 2017	BUY	$25.1 - $31.05 $3.19 Million - $3.94 Million	127,000	127,000 $3.94 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.